Spero Therapeutics Inc. (SPRO)
NASDAQ · Healthcare
Spero Therapeutics Inc. Shareholder Equity 2016–2025
Spero Therapeutics Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Spero Therapeutics Inc. shareholder equity as of December 31, 2025: 59.0M, a 27.96% increase year-over-year.
- Spero Therapeutics Inc. shareholder equity for 2025 were 59.0M, a 27.96% increase from 2024.
- Spero Therapeutics Inc. shareholder equity for 2024 were 46.1M, a 56.85% decrease from 2023.
- Spero Therapeutics Inc. shareholder equity for 2023 were 106.9M, a 40.77% increase from 2022.
- Spero Therapeutics Inc. shareholder equity for 2022 were 75.9M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Spero Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $59 |
| 2024 | $46 |
| 2023 | $107 |
| 2022 | $76 |
| 2021 | $88 |
| 2020 | $132 |
| 2019 | $75 |
| 2018 | $116 |
| 2017 | $85 |
| 2016 | $-45 |
Spero Therapeutics Inc. Shareholder Equity — FAQ
Spero Therapeutics Inc. (SPRO) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SPRO's shareholder equity history?
The chart and table above show Spero Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.